Lunch & Learn with Neurology Residents - Functional Neurological Disorders

Wednesday, January 8, 2025, 1:00 PM - Saturday, January 8, 2028, 2:00 PM

ANCC Nursing Contact Hours (1.00 hours), General Attendance (1.00 hours)

This education series is intended to address the knowledge gaps surrounding neuro-specific conditions and interventions provided to patients within neuroscience care areas.

Presenter

John Mason, DO
Resident, GME Neurology
Dartmouth Hitchcock Medical Center

1. Summarize history of FND.
2. Describe FND, including possible etiology, common risk factors and misconceptions.
3. Discuss evaluation, diagnosis, and outcomes of functional seizures.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hour. 

All other learners may claim General Attendance credit. Consult your professional licensing board regarding the applicability and acceptance of General Attendance credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion

You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.

2. Register for the activity.

3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.

4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).

5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.

6. Complete and Submit the Evaluation.

 

Bibliographic Sources

1. Wo Tasca C, Rapetti M, Carta MG, Fadda B. Women and hysteria in the history of mental health. Clin Pract Epidemiol Ment Health. 2012;8:110-9. doi: 10.2174/1745017901208010110. Epub 2012 Oct 19. PMID: 23115576; PMCID: PMC3480686.
   
   
2. Raynor G, Baslet G. A historical review of functional neurological disorder and comparison to contemporary models. Epilepsy Behav Rep. 2021 Oct 7;16:100489. doi: 10.1016/j.ebr.2021.100489. PMID: 34755104; PMCID: PMC8564048.
   
   
3. Picture. https://www.plannedparenthood.org/planned-parenthood-south-east-north-florida/blog/the-history-of-hysteria-and-how-it-impacts-you
   
   
4. Edwards, Yogarajah, M., & Stone, J. (2023). Why functional neurological disorder is not feigning or malingering. Nature Reviews. Neurology, 19(4), 246–256. https://doi.org/10.1038/s41582-022-00765-z
   
   
5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
   
   
6. Diez I, Ortiz-Terán L, Williams B, et al Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder Journal of Neurology, Neurosurgery & Psychiatry 2019;90:929-938.
   
   
7. Kelmanson AN, Kalichman L, Treger I. Physical Rehabilitation of Motor Functional Neurological Disorders: A Narrative Review. Int J Environ Res Public Health. 2023 May 11;20(10):5793. doi: 10.3390/ijerph20105793. PMID: 37239521; PMCID: PMC10218322.
   
   
8. Diez, I., Williams, B., Kubicki, M., Makris, N., & Perez, D. (2021). Reduced limbic microstructural integrity in functional neurological disorder. Psychological Medicine, 51(3), 485-493. doi:10.1017/S0033291719003386
   
   
9. Kozlowska, K., Scher, S., & Helgeland, H. Functional Somatic Symptoms in Children and Adolescents: A Stress-System Approach to Assessment and Treatment. 1st ed. 2020. 
   
   
10. Pick S, Goldstein LH, Perez DL, Nicholson TR. Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda. J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):704-711. doi: 10.1136/jnnp-2018-319201. Epub 2018 Nov 19. PMID: 30455406; PMCID: PMC6525039.
    
    
11. Sasikumar S, Strafella AP. The neuroimaging evidence of brain abnormalities in functional movement disorders. Brain. 2021 Sep 4;144(8):2278-2283. doi: 10.1093/brain/awab131. PMID: 33744915; PMCID: PMC8418342.
    
    
12. https://neurosymptoms.org/
    
    
13. https://emottawablog.com/2018/10/functional-neurological-disorders/
    
    
14. The Truth about Psychogenic Nonepileptic Seizures https://www.epilepsy.com/stories/truth-about-psychogenic-nonepileptic-seizures
    
    
15. PNES Epidemiology: What is known, what is new?https://doi.org/10.1016/j.ejtd.2019.100136
    
    
16. Mayor et al. Management of patients with nonepileptic attack disorder in the United Kingdom: A survey of health care professionals. Epilepsy & Behavior 21(2011)402–406
    
    
17. Villagrán, Eldøen, G., Duncan, R., Aaberg, K. M., Hofoss, D., & Lossius, M. I. (2021). Incidence and prevalence of psychogenic nonepileptic seizures in a Norwegian county: A 10?year population?based study. Epilepsia (Copenhagen), 62(7), 1528–1535. https://doi.org/10.1111/epi.16949
    
    
18. Nonepileptic Seizures Task Force. Epilepsia 2013; 54(11): 2005–2018.
    
    
19. Nightscales, McCartney, L., Auvrez, C., Tao, G., Barnard, S., Malpas, C. B., Perucca, P., McIntosh, A., Chen, Z., Sivathamboo, S., Ignatiadis, S., Jones, S., Adams, S., Cook, M. J., Kwan, P., Velakoulis, D., D?Souza, W., Berkovic, S. F., & O?Brien, T. J. (2020). Mortality in patients with psychogenic nonepileptic seizures. Neurology, 95(6), e643–e652. https://doi.org/10.1212/WNL.000000000000985
    
    
20. Kerr, W. T., Janio, E. A., Le, J. M., Hori, J. M., Patel, A. B., Gallardo, N. L., Bauirjan, J., Chau, A. M., D'Ambrosio, S. R., Cho, A. Y., Engel, J., Jr, Cohen, M. S., & Stern, J. M. (2016). Diagnostic delay in psychogenic seizures and the association with anti-seizure medication trials. Seizure, 40, 123–126. https://doi.org/10.1016/j.seizure.2016.06.015
    
    
21. ILAE. Tonic clonic seizure
    
    
22. Xiang, X., Fang, J. & Guo, Y. Differential diagnosis between epileptic seizures and psychogenic nonepileptic seizures based on semiology. Acta Epileptologica 1, 6 (2019). https://doi.org/10.1186/s42494-019-0008-4)
    
    
23. Functional Neurological Disorder workbook. FND Australia 2017 https://fndaustralia.com.au
    
    
24. Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022 Jun;21(6):537-550. doi: 10.1016/S1474-4422(21)00422v1. Epub 2022 Apr 14. Erratum in: Lancet Neurol. 2022 Jun;21(6):e6. PMID: 35430029; PMCID: PMC9107510.
    
    
25. O'Neal MA, Baslet GC, Polich GR, Raynor GS, Dworetzky BA. Functional Neurologic Disorders: The Need for a Model of Care. Neurol Clin Pract. 2021
    
    
26. Sara A. Finkelstein, Stoyan Popkirov, Functional Neurological Disorder: Diagnostic Pitfalls and Differential Diagnostic Considerations,Neurologic Clinics,
    Volume 41, Issue 4, 2023,Pages 665-679,https://doi.org/10.1016/j.ncl.2023.04.001.
    
    

 

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.